Estrovera By Metagenics Overview & Drug Interactions
Check For Interactions With Estrovera
Supplement: Estrovera by Metagenics
Estrovera Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Rhapontic Rhubarb (Rheum rhaponticum L.) root extract
Rhubarb is a plant part of the Polygonaceae family. It is a popular ingredient in cooking and the root is used as a food flavoring agent. The stalk, root, and rhizome of rhubarb are sometimes used medicinally for a variety of ailments, including menopausal symptoms, pancreatitis and gastrointestinal conditions. The leaves of the rhubarb plant contain oxalic acid and are toxic. They should not be consumed.
See More Information Regarding Rhubarb| Ingredient Group | Rhubarb |
|---|---|
| Category | botanical |
-
Rhaponticin
Ingredient Group Rhaponticin Category non-nutrient/non-botanical
Desoxy-Rhaponticin
Ingredient Group Rhaponticin Category non-nutrient/non-botanical
Drugs that interact with Estrovera by Metagenics
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
1 Tablet(s)
|
| Maximum serving Sizes: |
1 Tablet(s)
|
| Servings per container | 56 |
| UPC/BARCODE | 755571947192 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Rhapontic Rhubarb (Rheum rhaponticum L.) root extract |
4 mg
|
Rhubarb |
--
|
| Rhaponticin |
2.2 mg
|
Rhaponticin |
|
| Desoxy-Rhaponticin |
1 mg
|
Rhaponticin |
|
| Other Ingredients: |
Microcrystalline Cellulose
Stearic Acid
Croscarmellose Sodium
Silica
Enteric Coating
Forms
|
|---|
Label Statments:
| Formula |
- Estrovera's key ingredient, ERr731, has been used safely and effectively for over 20 years and is supported by clinical studies.
- Featuring ERr 731
- Plant-derived menopausal hot flash relief
|
|---|---|
| Formulation |
- Estrovera provides relief for multiple menopausal symptoms, including hot flashes, sleep disturbances, mood swings, irritability, anxiety, and sexual problems.
Visit MetaDispensary.com for additional information.
- This product is non-GMO, gluten-free, and vegetarian.
- This product is non-GMO, gluten-free, and vegetarian.
- Highly Efficacious
Formulated with ERr 731, which has shown up to 83% reduction in menopausal symptoms
- 83% decrease in daily hot flashes
ERr 731 delivers non-hormonal hot flash relief, with up to an 83% decrease in daily hot flashes and other menopausal symptoms.
|
| Suggested/Recommended/Usage/Directions |
- Directions: Take one tablet with food and a glass of water once daily at the same time of day or as directed by your healthcare practitioner.
- Simple dosing
Well-tolerated, once-daily tablet
|
| Precautions |
- Caution: Do not use if pregnant or nursing.
If taking medication, consult your healthcare practitioner before use.
- This product is contraindicated for individuals with any known or suspected estrogen-dependent cancer.
|
| Storage |
- Storage: Keep tightly closed in a cool, dry place.
|
| Seals/Symbols |
- GF Certified gluten-free
|
| FDA Disclaimer Statement |
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
|
| General Statements |
- 8 7-Tablet Bottles
- Exceptional safety profile
ERr 731 recommended by healthcare professionals in Europe since 1993
- Extensively studied
Multiple well-designed, randomized, double-blind placebo-controlled studies
- This estimated ratio is not included in the publication of cumulative results of a 12-week study followed by 2 48-week observational studies (OS). It is calculated from the mean change of the MRS II total score of 5.7 at the end of the first 48-week OS divided by the baseline score of 34. There was no change in total score from the end of the first OS to the end of the second OS. These results are from the ERr 731 subgroup only, which was administered ERr 731 daily for a total of 108 weeks. This calculation does not take into account some changes in study population over time.
- 12-week study of 112 perimenopausal women
- ERr 731 subjects reported a significant decrease in the median number of daily hot flashes compared to subjects taking placebo
- Kaszkin-Bettag M, Ventskovsky BM, Solskyy S, et al. Confirmation of the efficacy of ERr 731 in perimenopausal women with menopausal symptoms. Altern Ther Health Med. 2009; 15(1):24-34.
|
| FDA Statement of Identity |
- Dietary Supplement
|
Brand Information
See all products by this brand
| Distrubuted by | |
|---|---|
| Name | Metagenics |
| City | Gig Harbor |
| State | WA |
| ZipCode | 98332 |
| Phone Number | 800 692 9400 |
| Web Address | metagenics.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.